Log In- Links
- Publisher Full Text
- Authors
- Turabi A
- Plunkett AR
- MESH
- Analgesics
- Animals
- Anti-Inflammatory Agents, Non-Steroidal
- Anticonvulsants
- Antidepressive Agents
- Antineoplastic Agents
- Autonomic Nerve Block
- Catechol O-Methyltransferase
- Chronic Disease
- Gene Therapy
- Humans
- N-Methylaspartate
- Neoplasms
- Pain
- Pain Management
- Polymorphism, Single Nucleotide
- Receptors, Opioid, mu
- Somatosensory Cortex
- Translational Medical Research
The application of genomic and molecular data in the treatment of chronic cancer pain.
Abstract
Many cancer patients will develop complex pain syndromes requiring aggressive, innovative, and comprehensive multimodal pain management strategies. Recently, data from both animal studies and clinical trials have allowed clinical research to focus on creating applicable clinical treatment strategies. This article is a review of genomic and molecular data, which has contributed to creating novel modalities for use in clinical pain management of patients with cancer-induced pain.
Links
Authors
Institution
Defense & Veterans Pain Management Initiative, Anesthesia & Operative Service, Walter Reed Army Medical Center, Washington, District of Columbia 20307, USA.
Source
Journal of surgical oncology 105:5 2012 Apr 1 pg 494-501MeSH
AnalgesicsAnimals
Anti-Inflammatory Agents, Non-Steroidal
Anticonvulsants
Antidepressive Agents
Antineoplastic Agents
Autonomic Nerve Block
Catechol O-Methyltransferase
Chronic Disease
Gene Therapy
Humans
N-Methylaspartate
Neoplasms
Pain
Pain Management
Polymorphism, Single Nucleotide
Receptors, Opioid, mu
Somatosensory Cortex
Translational Medical Research
Pub Type(s)
Journal ArticleReview
Language
eng
PubMed ID
22441902